Menu

Star on GitHub · 3.4k

CVE-2026-0315

A local privilege escalation vulnerability in the Palo Alto Networks GlobalProtect™ app enables a local user to escalate their privileges to root on macOS.

Published Oct 14, 2026CWE-426EPSS 0.10%

Overview

CVE-2026-0315 is a known-severity vulnerability. It was published on October 14, 2026.

Technical description

A local privilege escalation vulnerability in the Palo Alto Networks GlobalProtect™ app enables a local user to escalate their privileges to root on macOS. This enables a non-administrative user to execute arbitrary commands with administrative privileges.

The GlobalProtect app on Linux, Windows, iOS, Android and Chrome OS is not affected by this vulnerability.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2026-0315?

CVE-2026-0315 is a known-severity vulnerability. It was published on October 14, 2026.

How severe is CVE-2026-0315?

CVSS score information is not yet available for this vulnerability. Check back as the CVE record is updated by NVD analysts.

How do I fix or remediate CVE-2026-0315?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2026-0315?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2026-0315 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

LiveWatch live →